Min Zheng

Title: Min Zheng: Innovator in Vaccine Development

Introduction

Min Zheng is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of vaccine development, particularly in creating innovative solutions for influenza viruses. With a total of 2 patents, his work focuses on enhancing vaccine safety and efficacy.

Latest Patents

Min Zheng's latest patents include a cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery. This invention provides compositions and methods for a live, attenuated influenza vaccine that can be administered nasally. The vaccine utilizes a cold adapted influenza virus that lacks virulence factors and includes mutations that ensure sufficient replicative ability for vaccine manufacture. This innovative vaccine offers significant cross-protection against non-vaccinating strains and is safe for children under the age of 2 and adults over 49 years of age. Additionally, he has developed live attenuated vaccines for influenza viruses, which involve genetically modified viral genomes. These modifications result in viruses that lose NS1 functionality while remaining replication competent.

Career Highlights

Throughout his career, Min Zheng has worked with notable organizations, including Versitech, Inc. and The University of Hong Kong. His expertise in vaccine development has positioned him as a key figure in the field.

Collaborations

Min Zheng has collaborated with esteemed colleagues such as Honglin Chen and Pui Wang, contributing to advancements in vaccine research and development.

Conclusion

Min Zheng's innovative work in vaccine development has the potential to significantly impact public health. His contributions to creating safer and more effective vaccines demonstrate his commitment to advancing medical science.